User profiles for ŁUKASZ SZYLBERG

Łukasz Szylberg

1. Department of Tumor Pathology and Pathomorphology, Oncology Center, Bydgoszcz …
Verified email at cm.umk.pl
Cited by 1093

The role of FOXP3 in human cancers

Ł Szylberg, D Karbownik, A Marszałek - Anticancer research, 2016 - ar.iiarjournals.org
FOXP3 transcription factor can be observed as the main component of the immune system
expressed in regulatory T (Treg) cells that regulate hemostasis and self-tolerance. Moreover, …

[HTML][HTML] Markers of pancreatic cancer stem cells and their clinical and therapeutic implications

…, W Bursiewicz, P Antosik, D Grzanka, Ł Szylberg - Molecular biology …, 2019 - Springer
Pancreatic cancer (PC) is the fourth most common cause of death among all cancers. Poor
prognosis of PC may be caused by a prevalence of cancer stem cells (CSCs). CSCs are a …

[HTML][HTML] Clinical relevance of BRAF V600E mutation status in brain tumors with a focus on a novel management algorithm

…, J Durślewicz, M Zdrenka, D Grzanka, Ł Szylberg - Targeted Oncology, 2020 - Springer
The possible application of BRAF-targeted therapy in brain tumors is growing continuously.
We have analyzed clinical strategies that address BRAF activation in primary brain tumors …

Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesisin the large bowel

A Marszałek, Ł Szylberg, E Wiśniewska… - Polish Journal of …, 2012 - termedia.pl
Impact of COX-2, IL-1β, TNF-α, IL-4 and IL-10 on the process of carcinogenesisin the large
bowel

Expression of metalloproteinases 2 and 9 and tissue inhibitors 1 and 2 as predictors of lymph node metastases in oropharyngeal squamous cell carcinoma

PK Burduk, M Bodnar, P Sawicki, Ł Szylberg… - Head & …, 2015 - Wiley Online Library
Background The matrix metalloproteinases (MMPs) and their tissue inhibitor of metalloproteinases
(TIMPs) can decompose extracellular matrix (ECM) components and brake down …

Diagnosis of Hirschsprung's disease with particular emphasis on histopathology. A systematic review of current literature

Ł Szylberg, A Marszałek - Gastroenterology Review/Przegląd …, 2014 - termedia.pl
Hirschsprung’s disease (HD) is a disorder that involves several medical specialties such as
paediatric gastroenterology, paediatric surgery, and pathology. Hirschsprung’s disease is a …

[HTML][HTML] Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review

Ł Szylberg, M Janiczek, A Popiel… - … research and practice, 2015 - hindawi.com
Colorectal cancer (CRC) is the third most frequently diagnosed cancer in the world. For a
long time, only one pathway of colorectal carcinogenesis was known. In recent years, a new “…

[HTML][HTML] Immunotherapy as a promising treatment for prostate cancer: a systematic review

M Janiczek, Ł Szylberg, A Kasperska… - Journal of immunology …, 2017 - hindawi.com
Prostate cancer treatment is currently based on surgical removal, radiotherapy, and
hormone therapy. In recent years, another therapeutic method has emerged—immunological …

[HTML][HTML] Emerging strategies in BRCA-positive pancreatic cancer

A Kowalewski, Ł Szylberg, M Saganek… - Journal of Cancer …, 2018 - Springer
Purpose We propose a treatment algorithm for PDAC with particular emphasis on BRCA1 or
2 mutation-positive patients. Pancreatic ductal adenocarcinoma (PDAC) is one of the …

Diagnostic algorithm in Hirschsprung's disease: focus on immunohistochemistry markers

P Galazka, L Szylberg, M Bodnar, J Styczynski… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Hirschsprung disease (HD) is caused by the congenital absence of
ganglion cells in the distal bowel (aganglionosis). Rectal biopsy is considered important for its …